News Feature: Serious Infections Still Common in Vasculitis Serious infections occurred more frequently among patients with ANCA-associated vasculitis who were given induction therapy with cyclophosphamide compared with rituximab (Rituxan). #RheumNow https://t.co/dTL6cReg8s https://t.co/U2sbEzd5DX